Friday, 30 June 2017
Bukola Bolarinwa Receives Award From Queen Elizabeth in The UK
Bukola Bolarinwa, a 28-Year-Old Nigerian lady has received the Queens Young Leaders Award from Queen Elizabeth of England.
Bukola is the founder of Haima Health Initiative, an online blood donation platform which supports hospitals who struggle to find blood in a safe and timely way.
The Queen’s Young Leaders Awards recognise and celebrate exceptional young people aged 18 to 29 in the Commonwealth who are driving change within their communities and transforming people’s lives.
Can drinking tea prevent dementia?
A study in the December 2016 Journal of Nutrition, Health & Aging
showed that drinking tea frequently is associated with a lower risk of
dementia, especially for people who are genetically predisposed to the
disease.
Researchers followed 957 older adults, average age 65, who were part of the Singapore Longitudinal Aging Study. Of these, 69% drank tea on a frequent basis. After a five-year period, the researchers found that the tea drinkers had a 50% lower risk of dementia. This is consistent with earlier findings that showed tea consumers scored higher on various cognitive tests.
The researchers also conducted genetic tests on the group and found that tea drinkers who carried the APOE4 gene variant, a known risk factor for Alzheimer's, were also at a lower risk compared with people who had APOE4 and did not drink tea.
How tea may help protect against dementia is not known, but other findings suggest that the brain-protecting effects of tea drinking could stem from bioactive compounds in tea leaves, such as flavonoids, which have anti-inflammatory and antioxidant potential, and L-theanine, which regulates neurotransmitter and brain activities.
It did not matter what kind of tea the people drank — black, green, and oolong all had the same association. The key was regular consumption, according to the scientists. The more the people drank tea, the stronger the relationship, and the best results were among those who had tea daily during the entire study period.
Published: July, 2017
In the Journals
Harvard Health Publications
Harvard Medical School
Researchers followed 957 older adults, average age 65, who were part of the Singapore Longitudinal Aging Study. Of these, 69% drank tea on a frequent basis. After a five-year period, the researchers found that the tea drinkers had a 50% lower risk of dementia. This is consistent with earlier findings that showed tea consumers scored higher on various cognitive tests.
The researchers also conducted genetic tests on the group and found that tea drinkers who carried the APOE4 gene variant, a known risk factor for Alzheimer's, were also at a lower risk compared with people who had APOE4 and did not drink tea.
How tea may help protect against dementia is not known, but other findings suggest that the brain-protecting effects of tea drinking could stem from bioactive compounds in tea leaves, such as flavonoids, which have anti-inflammatory and antioxidant potential, and L-theanine, which regulates neurotransmitter and brain activities.
It did not matter what kind of tea the people drank — black, green, and oolong all had the same association. The key was regular consumption, according to the scientists. The more the people drank tea, the stronger the relationship, and the best results were among those who had tea daily during the entire study period.
Published: July, 2017
In the Journals
Harvard Health Publications
Harvard Medical School
Don't Joke With Your Life: Checkout The Cancer Symptoms You Must Never Ignore At All
Cancer
is a killer disease that has destroyed many lives over the years,
however some people are still unaware of the signs they should look out
for.
When it comes to aches, pains, and other health problems, just
because something seems minor doesn’t mean you shouldn’t take it
seriously. In fact, research finds that even common ailments can
actually be the first warning signs of cancer. In a survey of 1,729
adults over the age of 50 in the UK published in PLOS ONE, respondents
evaluated how serious they perceived a list of 17 ailments—10 of which
were actually markers of cancer.
They also indicated whether they’d experienced any of these
symptoms recently and, if so, how they actually handled it.Turns out,
many people aren’t paying as much attention to warning signs as they
could be, says study author Katriina Whitaker, a senior research fellow
at University College London. “Some people don’t think they [the
symptoms] are serious, and cancer does not leap to mind.”
While for the vast majority, “these warning signs will not indicate cancer,” Whitaker says.
1. Lumps or bumps
It’s best to have any strange lumps checked out by a doctor. In the
survey, 7.5 per cent of people reported an unexplained lump. While 67
per cent did contact their doctors, 77 per cent didn’t think it could be
a sign of something more serious.
2. Cough or hoarseness
It’s cold and flu season, so coughing can feel like a given.
However, if your cough persists, it could indicate laryngeal, lung, or
thyroid cancer or lymphoma. This was the most common symptom among
survey participants. “We know coughs and colds are everywhere at the
moment, and we’re not suggesting everyone with a cough goes to their
doctor,” Whitaker said. “But if you have a symptom that doesn’t go away
or is unusual, don’t be afraid to go to your doctor for advice.”
3. Change in bowel habits
In Whitaker’s study, 18 per cent of people had experienced changes
in the timing, amount, or size of their bowel movements. While these
disruptions are usually caused by certain foods or medication, if you
notice it happens regularly over time, it could also be a sign of colon
cancer.
4. Bleeding
Coughing up blood can signal lung cancer; blood in the stool could
be a sign of colon or rectal cancer. Women who experience unexplained
vaginal bleeding should be checked for cervical or endometrial cancer. A
bloody discharge from the nipple can signal breast cancer, while blood
in the urine can mean you have bladder or kidney cancer. Unusual
bleeding can occur during any phase of cancer and warrants a visit to
your doctor.
5. A long-lasting sore throat
A sore throat may be just another winter woe, but a persistent one
could point to something more severe, such as laryngeal cancer or throat
cancer. Of those surveyed, nearly 78 per cent didn’t think throat woes
were serious.
6. Unexplained pain
Persistent pain is your body’s way of signaling a problem, and that
could be anything from nothing…to bone cancer or ovarian cancer. The
American Cancer Society says that pain from cancer typically means it
has spread—a good reason not to be a stoic and to make an appointment
with your physician. One striking finding from Whitaker’s survey: Only
about 40 per cent of people in the study were concerned that pain could
be a serious issue.
7. Variation in bladder activity
Because urinary tract infections are common in women, this symptom
is often disregarded as just another UTI. But whether you’re male or
female, if you notice blood in your urine, experience sudden urgency, or
feel pain while going, definitely bring it up with your doctor to rule
out cancers of the bladder, kidney, or prostate.
Tuesday, 13 June 2017
Fatigue is a symptom
Fatigue is a symptom, not a disease, and it is experienced differently
by different people. Fatigue from stress or lack of sleep usually
subsides after a good night’s rest, while other fatigue is more
persistent and may be debilitating even after restful sleep.
Breakthrough in stroke treatment: Stent thrombectomy
A randomized clinical research study looked at the effectiveness of a
new treatment for stroke. The study involved adding a minimally invasive
clot removal procedure called stent thrombectomy to standard
clot-dissolving therapy, known as tissue plasminogen activator. The
study showed a dramatic improvement in restoring blood flow back to the
brain, which is critical in the recovery of stroke.
Senior (stock image). The addition of stent
thrombectomy to standard clot-dissolving treatment led to 71 percent of
patients returning to independent living, compared with 40 percent in
the standard treatment group.
Credit: © Barabas Attila / Fotolia
Clot removal therapy effective outside six-hour window for some stroke patients
Results of a randomized controlled trial show
that endovascular treatment (ET) to remove a stroke-causing blood clot
in the brain is effective in some patients even when performed within 6
to 24 hours after a stroke. Current guidelines for acute stroke
treatment endorse clot removal only when performed within six hours of a
stroke. The findings are presented at the European Stroke
Organisation Conference 2017 in Prague.
"This still means that you need to be rushed to the hospital as soon
as possible after a stroke has occurred because the mantra "time is
brain" still holds. However, our study shows that even if treated
outside the time window, patients will have significantly reduced
disability with clot removal," said Tudor Jovin, M.D., director, UPMC
Stroke Institute, and professor of neurology and neurosurgery at the
University of Pittsburgh, who co-led the trial.
The trial sets a new selection paradigm based on physiology, showing for the first time that looking at patients fulfilling certain imaging and clinical criteria, physiological state of the brain is a much better approach to determining whether patients will benefit from endovascular therapy as opposed to adhering to strict time windows, noted co-principal investigator Raul Nogueira, M.D., professor of neurology, neurosurgery and radiology at Emory University School of Medicine, and director of neuroendovascular service and neurocritical care service at Marcus Stroke & Neuroscience Center, Grady Memorial Hospital.
In the study, researchers randomly assigned stroke victims who arrived at the hospital outside the six-hour time window to either receive endovascular therapy or receive only standard medical therapy.
Brain imaging and clinical information (neurological deficit) was used to identify and enroll patients who had a small area of irreversibly damaged brain and a significantly larger brain tissue area that was imminently threatened by loss of blood supply, but still alive -- a criterion known as clinical core mismatch.
The results showed that almost half of the patients (48.6 percent) receiving endovascular therapy had a good outcome at 90 days after treatment -- defined as the patients being independent in activities of daily living -- showed clinical benefit while only 13.1 percent showed benefit in the group that received clot-busting drugs alone. There was no difference in mortality between the two groups.
The researchers planned to enroll 500 patients over the course of the study period. However, an intermediate review of the treatment effectiveness before enrollment was completed led the independent Data Safety Monitoring Board overseeing the study to recommend early termination of the trial after it was demonstrated that ET provided significant clinical benefit in the selected patients.
The multi-center international study known as the DAWN trial included trial locations in the United States, Spain, France, Australia and Canada. The trial was sponsored by Stryker Corporation, which manufactures the clot removal devices used in the study.
The trial sets a new selection paradigm based on physiology, showing for the first time that looking at patients fulfilling certain imaging and clinical criteria, physiological state of the brain is a much better approach to determining whether patients will benefit from endovascular therapy as opposed to adhering to strict time windows, noted co-principal investigator Raul Nogueira, M.D., professor of neurology, neurosurgery and radiology at Emory University School of Medicine, and director of neuroendovascular service and neurocritical care service at Marcus Stroke & Neuroscience Center, Grady Memorial Hospital.
In the study, researchers randomly assigned stroke victims who arrived at the hospital outside the six-hour time window to either receive endovascular therapy or receive only standard medical therapy.
Brain imaging and clinical information (neurological deficit) was used to identify and enroll patients who had a small area of irreversibly damaged brain and a significantly larger brain tissue area that was imminently threatened by loss of blood supply, but still alive -- a criterion known as clinical core mismatch.
The results showed that almost half of the patients (48.6 percent) receiving endovascular therapy had a good outcome at 90 days after treatment -- defined as the patients being independent in activities of daily living -- showed clinical benefit while only 13.1 percent showed benefit in the group that received clot-busting drugs alone. There was no difference in mortality between the two groups.
The researchers planned to enroll 500 patients over the course of the study period. However, an intermediate review of the treatment effectiveness before enrollment was completed led the independent Data Safety Monitoring Board overseeing the study to recommend early termination of the trial after it was demonstrated that ET provided significant clinical benefit in the selected patients.
The multi-center international study known as the DAWN trial included trial locations in the United States, Spain, France, Australia and Canada. The trial was sponsored by Stryker Corporation, which manufactures the clot removal devices used in the study.
Story Source:
Materials provided by University of Pittsburgh Schools of the Health Sciences. Note: Content may be edited for style and length.
Materials provided by University of Pittsburgh Schools of the Health Sciences. Note: Content may be edited for style and length.
Ladies, Be Careful: These are the Early Breast Cancer Symptoms You Should Never Ignore
Breast
cancer is a dangerous ailment that has claimed the lives of many women
over the years. These are some of the signs of breast cancer you should
not joke with.
Most people know to look for lumps, but there are many other symptoms that you probably don't know about.
With one in two people now getting cancer at some point in their lifetime, the threat is more evident than ever.
Breast cancer was the most common cancer worldwide in women
contributing more than 25% of the total number of new cases diagnosed in
2012.
There were 53,696 new cases of breast cancer in the UK alone in 2013 and 11,433 deaths in 2014.
Thankfully due to increasing awareness and advances in treatment
the survival rate is now 78%, but it's important to catch it early.
While most people know to look out for lumps and bumps, there are a
whole host of other warning signs that aren't spoken about as often.
October is breast cancer awareness month and in a bid to raise awareness, here are nine early symptoms you should look out for:
1. Lump or thickening in your breast or armpit
2. Change to the skin of your breast
3. Changes in the shape or size of your breast
4. Dimpling of the skin or thickening in the breast tissue
5. A nipple that's turned in (inverted)
6. A rash (like eczema) on the nipple
7. Nipple changes or discharge
8. Pain in your breast
9. Any other unusual or persistent changes to your breast
What should I do if I have any of these symptoms?
See your GP as soon as possible if you notice any symptoms of
breast cancer. Your GP will examine you. If they think your symptoms
need further assessment they'll refer you to a specialist breast cancer
clinic.
Don't be worried about wasting your doctor's time – it's always better to be safe than sorry.
How is breast cancer diagnosed?
The most common way doctors look for breast cancer in women is to
identify lumps in the breast. They most often do this with mammogram
x-rays and sometimes an ultrasound scan – usually in women over 35.
These tests will detect whether there are any unusual lumps or
bumps inside the breast. If they find anything worrying they will then
do a biopsy, where a sample of tissue cells is taken from the breast to
see if it's cancerous.
You may also need a scan and a needle test on lymph nodes in your armpit (axilla) to see whether these are also affected.
If you do have a cancerous lump, your specialist will then decided the best corse of treatment.
How is breast cancer treated?
Due to medical advances there are now a whole host of different treatment options for breast cancer.
Depending on your exact diagnosis you may have a combination of any
of the following: surgery, radiation, hormonal (anti-estrogen) therapy
and chemotherapy.
There are also complementary and holistic medicines and techniques
such as yoga and meditation, that can be given alongside stronger
treatment.
Culled from Daily Star UK
Subscribe to:
Posts (Atom)